Delian Capital is a leading venture capital firm focusing on Pre-A to B round stage since founded in 2011. Their team specializes in the areas of the high-end manufacturing, cutting-edge technologies and healthcare. Delian has invested in dozens of startups in multiple industry segments, including robotics, intelligent hardware, green energy, AI, big data, enterprise services and healthcare. Delian has a professional team that upholds a value investment philosophy and adheres to become a long-term, reliable business partner with their portfolio companies and co-investors.
Headquartered in Beijing, Lapam Capital is a leading healthcare-focused venture capital firm in China, with over RMB 2 billion of capital under management. Lapam Capital targets both early stage and fast-growing opportunities, and has built a strong investment portfolio with innovative and disruptive healthcare technology. Lapam Capital has already invested in dozens of Chinese pharmaceutical companies, which together have generated nearly half of all Class I new small molecule drugs marketed by privately-held companies in China. Lapam Capital provides comprehensive value-added services tailored for a healthcare portfolio.